Crossmark

Revisiting NICE guidelines for initiation of intravitreal anti-VEGF therapy for centre-involving diabetic macular oedema: a survey of current interpretation in the United Kingdom

Crossref DOI link: https://doi.org/10.1038/s41433-022-01935-5

Published Online: 2022-01-25

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dinah, Christiana https://orcid.org/0000-0002-0815-4771
Myers, Sam https://orcid.org/0000-0001-6050-4663
Pushpoth, Sreekumari

Degli-Esposti, Simona
License Information

Text and Data Mining valid from 2022-01-25

Version of Record valid from 2022-01-25
More Information

Article History

Received: 20 September 2021

Revised: 9 January 2022

Accepted: 12 January 2022

First Online: 25 January 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below